A global research collaboration has revealed how certain gut cells switch on pain signals, which can linger long after the ...

USAISR is working with MIT Lincoln Lab to develop a new device for providing regional pain control in trauma patients at or ...

In today’s fast-paced world, many individuals experience nerve discomfort due to various factors, including age, lifestyle, ...

According to the company, the suffix “-mod” in urcosimod denotes its classification as a modulator of key inflammatory and ...

LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company specializing in the development of treatments for ocular conditions and currently valued at $37 million, has ...

The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of ...

GRAND FORKS — A Grand Forks man is celebrating the success of a relatively new procedure for amputees, which has changed his ...

Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

(THE CONVERSATION) Chronic pain affects hundreds of millions of people around the world. But the opioid crisis in North America led many health care providers to realize they relied too heavily on ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...